Over-the-counter osteoporosis drug appears to keep astronauts from losing bone density on long space flights

Big news: New research on ISS now shows that the standard over-the-counter osteoporosis drugs used by millions on Earth appears to keep astronauts from losing bone density during long space flights.

Beginning in 2009, the group administered the drug to five long-stay astronauts on the International Space Station (ISS), including Koichi Wakata, 48, and Soichi Noguchi, 46. The five took the drug — an over-the-counter bisphosphonate used to treat osteoporosis — once a week starting three weeks before they lifted off until they returned to Earth. The researchers then monitored the astronauts’ bone mass over time and compared the results to those for 14 astronauts that had never taken the drug.

The results showed that the 14 who had never taken the drug had average bone density loss of 7 percent in the femur, and 5 percent in the hip bone. The five astronauts on bisphosphonate, however, only had average bone density loss in the femur of 1 percent, and even a 3 percent increase in the hip bone. Calcium levels in their urine, which rise the more bone mass is lost, were also very low.

If these results hold up, they might very well solve one of the biggest challenges faced by any interplanetary traveler. Up until now, bone loss during long weightless missions never seemed to average less than 0.5 percent per month. After spending three years going to and from Mars, an astronaut could thus lose about almost 20 percent of their bone mass in their weight-bearing bones, and would probably be unable to return to Earth.

Thus, a mission to Mars seemed impossible, unless we could build a ship with some form of artificial gravity, an engineering challenge we don’t yet have the capability to achieve.

If these already tested drugs can eliminate this problem, then the solar system is finally open to us all. All that has to happen now is to do some one to two year manned missions on ISS to test the drugs effectiveness for these long periods of weightlessness.

3 comments

A new study has been released detailing the vision problems experienced by astronauts on space flights longer than six months

A new study has been released detailing the vision problems experienced by astronauts on space flights longer than six months. Hat tip to Clark Lindsey.

The visual system changes discovered by the researchers may represent a set of adaptations to microgravity. The degree and type of response appear to vary among astronauts. Researchers hope to discover whether some astronauts are less affected by microgravity and therefore better-suited for extended space flight, such as a three-year round trip to Mars.

In their report, Drs. Mader and Lee also noted a recent NASA survey of 300 astronauts that found that correctible problems with both near and distance vision were reported by about 23 percent of astronauts on brief missions and by 48 percent of those on extended missions. The survey confirmed that for some astronauts, these vision changes continue for months or years after return to Earth.

0 comments

Eradicating polio: not this year

The effort to eradicated polio entirely by the end of 2012 will not be met.

Afghanistan and Nigeria, two of the three remaining endemic countries, have had more cases in the first nine months of this year than in 2010 altogether. Several other countries targeted by the plan have also seen more cases to date this year compared to this time in 2010. Additionally, polio had popped up in countries where it had previously been eradicated โ€” notably China, which went polio-free for 11 years until this summer.

Sadly, politics and culture are almost certainly the main reasons polio still survives in these countries.

1 comment

Human bones taken to ISS for long space flight experiments.

Human bones were part of the cargo on board the Soyuz capsule launched to ISS today.

โ€œThe fragments of human bones will be used to study the causes and dynamics of decalcination of bone tissue in a long space flight,โ€ the head of the experiment, Tatiana Krasheninnikova told Itar-Tass. The problem of decalcination is a headache for medics responsible for spacemenโ€™s health. Researches in this area are conducted by scientists from many ISS member states. However it is impossible to take sample of spacemenโ€™s bones, only their urine is being examined, and a complete picture of dynamics of changes in human bones is not clear, she noted.

0 comments

Fraud in drug studies investigated

A research anesthesiologist has been stripped of his professorship, fired from a German hospital, and is under criminal investigation for forging the medical research for more than 90 papers. Key paragraph:

German medical authorities are examining 92 of Boldt’s published papers amid allegations he forged documents, tested drugs on patients without their consent and fraudulently claimed payments for operations he never performed. Twenty-nine of the 92 papers have been identified as “highly suspected” of containing forged or distorted data, authorities said.

One third or more of his peer-reviewed papers are now suspect? Isn’t it the claim of peer-review science journals that this kind of fraud is impossible because the work will be carefully reviewed by the best people, most qualified to spot any fraud in their field? Yet, in this case this system failed at least one third of the time, if not more so, and did so frequently.

To me, this is further evidence that the best method for finding fraud is not review, but independent competition. Let others challenge the result or try to duplicate it. That way, we find out very quickly whether it is real or not.

1 comment

Peer-reviewed journal article a “Fraud”

Back in 1998 a peer-reviewed paper in the medical journal, Lancet, claimed that the childhood vaccinations for measles, mumps and rubella vaccine could be linked to autism and other health problems. The consequence was that thousands of parents withheld vaccinations from their children, resulting in an outburst of measles that almost certainly did actual harm to many children.

This paper has now been shown to be an outright fraud.

This story raises two thoughts. First, it demonstrates clearly that just because a research paper is published in a “peer-reviewed” science journal is no guarantee that the paper will be honest, reliable, or factually accurate. As good scientists like to say, “Extraordinary results require extraordinary evidence.” Both the press and public need to be constantly skeptical about all research, regardless of where it is published.

Secondly, the reaction of the journal, Lancet, to this whole affair suggests strongly that this particular journal is even more unreliable than most. To quote:

The Lancet withdrew the article in January of last year after concluding that “several elements” of the paper were incorrect. But the journal didn’t describe any of the discrepancies as fraud.

The journal’s reaction is similar to what we saw with the climategate emails, an effort to whitewash the situation while refusing to face the problem bluntly and fix it. If the article was as fraudulent as the Wall Street Journal article above suggests, it raises serious questions about the editorial policies at Lancet. That the editors there seem uninterested in addressing these concerns acts to discredit their publication entirely. And until they deal with this issue properly, I would look very skeptically on anything they publish.

(Note that this is not the first time Lancet has published research of questionable reliability. See this story for another example.)

0 comments
1 2